Brief: NantHealth, NantKwest and NantOmics announce availability of GPS cancer and phase i - iii quilt trials through the U.S. National Institutes of Health's ClinicalTrials.gov

Nanthealth

08/12/2016 13:00

Dec 8 (Reuters) - NantHealth Inc  NH.O  
    * NantHealth, NantKwest and NantOmics announce availability 
of GPS cancer and phase i - iii quilt trials through the U.S. 
National Institutes of Health's ClinicalTrials.gov 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw37cb7da 
Further company coverage:  NH.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))